APWA
MRK icon

Atlas Private Wealth Advisors’s Merck MRK Stock Holding History

Atlas Private Wealth Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,811
Closed -$218K – 140
2026
Q1 		$218K Sell
1,811
-266
-13% -$30.7K 0.05% 128
2025
Q4 		$219K Buy
+2,077
New +$195K 0.05% 127
2025
Q3 		– Sell
-8,589
Closed -$680K – 178
2025
Q2 		$680K Sell
8,589
-4,809
-36% -$382K 0.09% 107
2025
Q1 		$1.2M Sell
13,398
-8,134
-38% -$759K 0.17% 74
2024
Q4 		$2.14M Buy
21,532
+396
+2% +$40.8K 0.3% 49
2024
Q3 		$2.4M Buy
21,136
+620
+3% +$73.7K 0.35% 39
2024
Q2 		$2.54M Buy
20,516
+10,294
+101% +$1.33M 0.41% 33
2024
Q1 		$1.35M Sell
10,222
-12,185
-54% -$1.5M 0.45% 30
2023
Q4 		$2.44M Sell
22,407
-14,437
-39% -$1.5M 0.45% 27
2023
Q3 		$3.79M Buy
36,844
+1,386
+4% +$149K 0.72% 23
2023
Q2 		$4.09M Buy
35,458
+15,044
+74% +$1.71M 0.83% 18
2023
Q1 		$2.17M Sell
20,414
-568
-3% -$61.3K 1% 16
2022
Q4 		$2.33M Sell
20,982
-3,172
-13% -$324K 1.24% 13
2022
Q3 		$2.08M Sell
24,154
-245
-1% -$21.9K 1.25% 16
2022
Q2 		$2.22M Sell
24,399
-2,139
-8% -$190K 1.33% 17
2022
Q1 		$2.18M Buy
26,538
+1,747
+7% +$138K 0.97% 21
2021
Q4 		$1.9M Sell
24,791
-539
-2% -$42.9K 0.88% 33
2021
Q3 		$1.9M Buy
25,330
+1,246
+5% +$94.8K 0.99% 21
2021
Q2 		$1.87M Sell
24,084
-275
-1% -$20.5K 1.01% 22
2021
Q1 		$1.79M Buy
24,359
+3,690
+18% +$272K 1% 24
2020
Q4 		$1.61M Buy
20,669
+381
+2% +$29.1K 1.08% 20
2020
Q3 		$1.61M Sell
20,288
-296
-1% -$23.2K 1.34% 15
2020
Q2 		$1.52M Buy
+20,584
New +$1.55M 1.35% 17

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Atlas Private Wealth Advisors's MRK Position: Q2 2026 in Review

Atlas Private Wealth Advisors sold out of Merck (MRK) in Q2 2026, closing a stake of 1,811 shares — an estimated $218K sold.

Atlas Private Wealth Advisors first reported a position in MRK in Q2 2020 and held it in 23 quarters. The position peaked at $4.09M in Q2 2023. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Atlas Private Wealth Advisors reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Atlas Private Wealth Advisors sold 1,811 Merck shares in Q2 2026, an estimated $218K.
  • Atlas Private Wealth Advisors first reported a position in Merck in Q2 2020 and held it in 23 quarters.
  • Atlas Private Wealth Advisors's Merck position peaked at $4.09M in Q2 2023.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Atlas Private Wealth Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.